Is worsening multiple organ failure the cause of death in patients with severe sepsis?
- PMID: 21317650
- DOI: 10.1097/CCM.0b013e31820eda29
Is worsening multiple organ failure the cause of death in patients with severe sepsis?
Abstract
Objectives: Although the mortality of severe sepsis is easily quantified, the actual cause and timing of death from severe sepsis are less defined. We used the INDEPTH (International Integrated Database for the Evaluation of Severe Sepsis and Drotrecogin alfa activated) database to investigate the reported cause of death in patients with severe sepsis.
Design: Retrospective database analysis.
Patients: Data from 4459 patients with severe sepsis (drotrecogin alfa activated, n = 3228; placebo, n = 1231) included in five clinical trials conducted in tertiary care institutions in 28 countries.
Measurements and main results: We examined the cause of death and the pattern of Sequential Organ Failure Assessment scores near the time of death. We also evaluated the time course of biomarker levels at this late stage. A total of 1201 (27.0%) patients died during the 28-day study period. The main causes of death were as follows: sepsis-associated multiple organ failure (43.1%), refractory septic shock (22.6%), and respiratory failure (13.0%). There were no significant differences in the distributions of cause of death between drotrecogin alfa activated and placebo patients, so that all patients were combined for analysis. The mean cardiovascular Sequential Organ Failure Assessment score increased from 2.4, 4 days before death, to 2.9, 1 day before death, and the mean respiratory Sequential Organ Failure Assessment score increased from 2.6, 4 days before death, to 2.9, 1 day before death. The increase in these individual Sequential Organ Failure Assessment scores was more prominent in patients who died early (day 0-5). Protein C levels decreased and interleukin-6 levels increased in the days before death.
Conclusion: Patients with severe sepsis typically die of multiple organ failure, refractory shock, or respiratory failure. Persistent, more than worsening, organ failure is the more common pattern before death.
Comment in
-
"Sepsis--it ain't so much what you don't know that gets you into trouble, it's what you know for sure that just ain't so."--with apologies to Mark Twain.Crit Care Med. 2011 May;39(5):1214-5. doi: 10.1097/CCM.0b013e3182148c03. Crit Care Med. 2011. PMID: 21610584 No abstract available.
Similar articles
-
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety.J Crit Care. 2007 Jun;22(2):142-52. doi: 10.1016/j.jcrc.2006.09.007. Epub 2007 Jan 31. J Crit Care. 2007. PMID: 17548026
-
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.Crit Care Med. 2003 Mar;31(3):834-40. doi: 10.1097/01.CCM.0000051515.56179.E1. Crit Care Med. 2003. PMID: 12626993 Clinical Trial.
-
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.Surgery. 2006 Nov;140(5):726-39. doi: 10.1016/j.surg.2006.06.009. Surgery. 2006. Corrected and republished in: Surgery. 2007 Apr;141(4):548-61. doi: 10.1016/j.surg.2007.02.004. PMID: 17084715 Corrected and republished.
-
Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.Drug Saf. 2007;30(11):995-1010. doi: 10.2165/00002018-200730110-00002. Drug Saf. 2007. PMID: 17973539 Review.
-
Role of activated protein C in the pathophysiology of severe sepsis.Am J Crit Care. 2003 Nov;12(6):518-24; quiz 525-6. Am J Crit Care. 2003. PMID: 14619357 Review.
Cited by
-
Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine.J Thorac Dis. 2019 Jan;11(1):21-28. doi: 10.21037/jtd.2018.11.74. J Thorac Dis. 2019. PMID: 30863561 Free PMC article. No abstract available.
-
Association between Mortality and Sequential Organ Failure Assessment Score during a Short Stay in the Intensive Care Unit after Non-Cardiac Surgery.J Clin Med. 2022 Oct 4;11(19):5865. doi: 10.3390/jcm11195865. J Clin Med. 2022. PMID: 36233732 Free PMC article.
-
Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells.Crit Care. 2013 Jul 24;17(4):R152. doi: 10.1186/cc12831. Crit Care. 2013. PMID: 23883738 Free PMC article.
-
The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses.Case Rep Crit Care. 2019 Sep 10;2019:6561018. doi: 10.1155/2019/6561018. eCollection 2019. Case Rep Crit Care. 2019. PMID: 31583137 Free PMC article.
-
Initial clinical outcomes and prognostic variables in the implementation of a Code Sepsis in a high complexity University Hospital.Rev Esp Quimioter. 2019 Jun;32(3):238-245. Epub 2019 Apr 9. Rev Esp Quimioter. 2019. PMID: 30968675 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical